HealthFDA Approves First mRNA Flu Vaccine for Adults Over 50
The US FDA has approved the first mRNA flu vaccine, named mFlusiva, developed by Moderna for adults aged 50 and above. Unlike traditional flu vaccines, this new vaccine uses mRNA technology to better protect against flu and other respiratory infections, which affect thousands annually in India. It is considered especially important for older adults to prevent severe illness.
News18 Hindi·5h ago



